Match Document Document Title
5962261 Polynucleotides encoding a neuronal extracellular matrix protein  
The present invention provides a human neuronal extracellular matrix protein (HNEP) and polynucleotide which encode HNEP. The invention also provides expression vectors, host cells, agonists,...
5961982 Recombinant herpesvirus of turkeys and uses thereof  
The present invention provides a recombinant herpesvirus of turkeys designated S-HVT-050 (ATCC Accession No. VR 2400). A vaccine is provided which comprises an effective immunizing amount of...
5958733 Threonyl tRNA synthetase polynucleotides  
The invention provides thrS polypeptides and DNA (RNA) encoding thrS polypetides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing thrS...
5958734 Polynucleotides encoding gluS polypeptides of streptococcus pneumoniae  
The invention provides gluS polypeptides and DNA (RNA) encoding gluS polypetides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing gluS...
5958736 Recombinant DNA coding for signal peptide, selective interacting polypeptide and membrane anchoring sequence  
Tripartite recombinant DNA encoding fusion proteins which comprise three sequences, i.e., a signal peptide which is operable in a Gram positive bacterium, an immunogenic polypeptide linked thereto...
5955077 Tuberculosis vaccine  
The invention relates to novel secreted antigens from mycobacteria capable of evoking early (within 4 days) immunological responses from T-helper cells in the form of gamma-interferon release in...
5955312 DNA encoding a novel microtubule-associated protein  
The present invention provides a human microtubule-associated protein (hLC3) and the polynucleotides which identify and encode hLC3. The invention also provides genetically engineered expression...
5955088 Pharmaceutical compsition of herpes simplex virus type-1 (HSV-1), glycoproteins  
The present invention relates to the field of infectious diseases and ophthalmology. More particularly, the invention relates to compositions and methods for vaccination against Herpes Simplex...
5955356 Nucleic acids, vectors, and host cells including mycobacterium derived sequences  
The invention relates to nucleic acids which contain particularly a nucleotide sequence extending from the extremity constituted by the nucleotide at position (1) to the extremity constituted by...
5955272 Detection of individual gene transcription and splicing  
Disclosed are in situ hybridization methods for differentially detecting an RNA and the gene from which it was transcribed, while preserving the spatial relationship of the RNA transcript and the...
5955313 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded uses thereof  
The invention involves the identification of an isolated nucleic acid molecule which encodes a tumor rejection antigen. Various uses of this nucleic acid molecule and the protein it encodes are...
5955596 NucA protein of Haemophilus influenzae and the gene encoding that protein  
A protein from H. influenzae designated NucA is isolated and purified. The NucA protein has the amino acid sequence of amino acids 26-603 of SEQ ID NO:2 or a biologically equivalent amino acid...
5955264 Rapid mutational analysis method  
A rapid mutational analysis method for mapping protein epitopes is disclosed. This method has been used to identify the binding sites for 16 anti-CD2 and anti-CD4 monoclonal antibodies. The...
5952196 Prolyl tRNA synthetase polynucleotides  
The invention provides proS polypeptides and DNA (RNA) encoding proS polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing proS...
5952195 Promoters for expressing proteins of interest in yeast  
The present invention provides novel nucleic acid fragments isolated from the genomic DNA of yeast and having transcription promoter activity, as well as expression cassettes, vectors, and host...
5952216 Synthetic HPV 16 virus-like particles  
A series of synthetic virus-like particles useful in the characterization of human papillomavirus type 16 (HPV16) infection and assays employing the synthetic particles are provided.
5952487 DNA sequences of the papillomavirus HPV42 for use in diagnosis  
DNA sequences derived from human papillomavirus HPV42 are disclosed. Also disclosed are methods of using these sequences as hybridization probes in diagnostic assays.
5948646 Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes  
The present invention relates to methods for preparing immunogenic, prophylactically and therapeutically effective complexes of heat shock proteins noncovalently associated with antigenic peptides...
5948676 Immediate early protein from Kaposi's sarcoma-associated herpesvirus, DNA encoding same and uses thereof  
This invention provides an isolated nucleic acid molecule which encodes Kaposi's Sarcoma-Associated Herpesvirus (KSHV) immediate early protein (IEP). This invention provides an isolated polypeptide...
5948644 Polynucleotides encoding excretory/secretory proteins of parasitic nematodes, host cells transformed therewith  
The invention provides excretory/secretory antigens derived from parasitic nematode species which are capable of inducing protective immunity against infection by parasitic nematode species, and...
5948645 Biosynthetic gene muri from Streptococcus pneumoniae  
The invention provides isolated nucleic acid compounds encoding the stem peptide biosynthetic gene murI of Streptococcus pneumoniae. Also provided are vectors and transformed heterologous host...
5945278 Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria  
The invention provides a method and expression system for enhancing secretion of hyperproduced homologous and heterologous exoproteins in gram-positive bacteria such as Bacillus sp. The method and...
5942434 Nucleic acid constructs comprising hypoxia response elements  
Nucleic acid constructs comprising hypoxia response elements in operable linkage with a coding sequence of a gene of interest are disclosed. In particular, such nucleic acid constructs comprise...
5935580 Recombinant mutants for inducing specific immune responses  
This invention relates to a recombinant plasmid comprising the cyaC and the cyaA genes of Bordetella which directs the expression of Bordetella adenylate cyclase in a transformed host cell. This...
5935838 Method of cultivating bacteria proteins that are expressed in a temperature regulated manner  
A method of cultivating bacteria having genes in plasmids which code for surface or membrane bound antigens or other proteins and which are expressed in a temperature regulated manner for the...
5935570 Synthesis of immunologic, therapeutic and prophylactic compounds by transformed clavibacter  
A process for the synthesis and delivery of bioactive compounds, compounds that have a therapeutic, biochemical, or immunologic, effect on an animal, such as human. In the process, clavibacter is...
5935818 Isolated nucleic acid molecule encoding alternatively spliced prostate-specific membrane antigen and uses thereof  
This invention provides an isolated mammalian nucleic acid molecule encoding an alternatively spliced prostate-specific membrane (PSM') antigen. This invention provides an isolated nucleic acid...
5932225 Vaccine comprising eimeria spp. gametocyte antigen  
Substantially purified Eimeria maxima gametocytes have been prepared and methods for their preparations are disclosed. A proteinaceous extract derived from the gametocytes comprises at least nine...
5932219 Hepatitis delta virus p27.sup.δ and p24.sup.δ vaccine  
The entire genome of the hepatitis D virus has been shown to be a circular single-stranded RNA of 1679 bases. Several open reading frames in both the genomic and complementary strands indicate...
5932705 Methods and compositions for the treatment and diagnosis of shipping fever  
Novel compositions are disclosed for use in the treatment or diagnosis of bovine pasteurellosis, commonly referred to as Shipping Fever. Cell-free Pasteurella haemolytica supernatants are employed...
5932220 Diagnostic tests for a new spirochete, Borrelia lonestari sp. nov.  
Bites from Amblyomma americanum, a hard tick, have been associated with a Lyme disease-like illness in the southeastern and south-central United States. Present in 2% of ticks collected in four...
5928651 Gene encoding high molecular surface protein-2 non-typeable haemophilus  
High molecular weight surface proteins of non-typeable Haemophilus influenzae which exhibit immunogenic properties and genes encoding the same are described. Specifically, genes coding for two...
5928901 Molecules containing at least one peptide sequence carrying one or several epitopes characteristic of a protein produced by P. falciparum in hepatocytes and compositions containing them  
The invention relates to a molecule comprising one or more peptide sequences of formula: TBL Leu-Ala-Lys-Glu-Lys-Leu-Gln-X-Gln-Gln-Ser-Asp-Leu- Glu-Gln-Glu-Arg in which X is Glu or Gly. It also...
5928895 IgA Fc binding protein  
The invention provides IgA Fc binding protein polypeptides and DNA (RNA) encoding IgA Fc binding protein polypeptides and methods for producing such polypeptides by recombinant techniques. Also...
5925734 Isolated Epstein-Barr virus BZLF2 proteins that bind MHC class II βchains  
Isolated viral proteins, and pharmaceutical compositions made therefrom, are disclosed which are capable of binding to a β chain of a Class II Major Histocompatibility Complex antigen, thereby...
5922327 Equine herpes virus glycoproteins  
Equine rhinopneumonitis and equine abortion are horse diseases caused by two distinct but antigenically related viruses designated as equine herpes virus 4 (EHV4) and equine herpes virus 1 (EHV1)....
5919454 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications  
This invention relates to human or murine monoclonal antibodies specific for a peptide sequence of HCV E1, fragments of said monoclonal antibodies, hybridomas producing said monoclonal antibodies,...
5919664 Peptide release factor, prfC (RF-3), a GTP-Binding protein  
The invention provides prfC polypeptides and DNA (RNA) encoding prfC polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing prfC...
5919462 Nucleic acid fragments derived from the HIV-1 virus genome, corresponding peptides and their applications as reagents for evaluation of the risk of maternofoetal transmission of HIV-1  
This invention provides specific amino acid sequences encoded by nucleic acid fragments derived from the genome of the human immunodeficiency virus type 1 (HIV-1) and to peptides containing such...
5916768 Contraceptive vaccine based on alloimmunization with zona pellucida polypeptides  
The present invention relates to contraceptive vaccines based on cloned zona pellucida genes and the strategy of alloimmunization with zona pellucida polypeptides. In particular, the present...
5910405 HCV diagnostic agents  
The present invention relates to the epitopes of hepatitis C virus (HCV) core protein and non-structural 3 protein (NS3), and the epitopes of envelope protein, epitopes of non-structural 4 protein,...
5908627 Antigen associated with Type I diabetes mellitus  
A 69 kD protein, designated PM-1, is expressed in human pancreatic islet cells and a human insulinoma. The amino acid sequence of the protein has been determined. Autoantibodies to the PM-1 protein...
5891442 Infectious bursal disease virus recombination poxvirus vaccine  
What is described is a recombinant poxvirus, such as fowlpox virus, containing foreign DNA from infectious bursal disease virus. What is also described is a vaccine containing the recombinant...
5891676 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system  
A method to express rotavirus genes in a baculovirus system. Different clones are used to express rotavirus genes for all of the viral proteins. These proteins are isolated in their native...
5891670 Tetracycline resistance protein  
The invention provides tetracycline resistance protein polypeptides and DNA (RNA) encoding tetracycline resistance protein polypeptides and methods for producing such polypeptides by recombinant...
5891678 DNA encoding the SecA1 polypeptide of Staphylococcus aureus  
The invention provides secA1 polypeptides and DNA (RNA) encoding secA1 polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utilizing...
5891677 Actinobacillus pleuropneumoniae outer membrane lipoprotein A and uses thereof  
Novel vaccines for use against Actinobacillus pleuropneumoniae are disclosed. The vaccines contain at least one Actinobacillus pleuropneumoniae outer membrane lipoprotein A, or an immunogenic...
5888770 Spoiiie  
The invention provides spoIIIE polypeptides and DNA (RNA) encodig spoIIIE polypeptides and methods for producing such polypeptides by recombinant techniques. Also provided are methods for utlizng...
5888516 Recombinant papillomavirus vaccines  
Recombinant expression vectors encoding the L1 and L2 proteins of papillomavirus, methods of making and using the recombinant proteins and purified virus-like particles comprised of the recombinant...
5888513 Recombinant PRRSV proteins, diagnostic kits and vaccines containing such recombinant PRRSV proteins  
Recombinant proteins of the causative virus of porcine reproductive and respiratory syndrome (PRRS), corresponding to ORFs 2 to 7 of the PRRSV Spanish isolate (PRRS-Olot), have been produced in...